Keyphrases
Electroconvulsive Therapy
100%
Major Depressive Disorder
77%
Treatment-resistant Depression
69%
Older Adults
60%
Transcranial Magnetic Stimulation
55%
Repetitive Transcranial Magnetic Stimulation (rTMS)
42%
Executive Function
25%
Third Trimester
23%
Catatonia
23%
Modified Electroconvulsive Therapy
23%
Treatment Outcome
21%
Intermittent theta Burst Stimulation (iTBS)
21%
Optimizing Outcomes
21%
Design Characteristics
21%
Clinical Practice
21%
Treatment Characteristics
21%
Late-life Depression
20%
Antidepressants
20%
Right Unilateral
20%
Executive Function Deficits
16%
Target Engagement
15%
Treatment-resistant
15%
Depressive Symptoms
14%
Psychiatry
14%
Vagus Nerve Stimulation
14%
Pregnant Women
14%
Antidepressant Treatment
13%
Second Trimester of Pregnancy
13%
Bupropion
12%
Academic Medical Centers
11%
Hamilton Depression Rating Scale (HAM-D)
11%
Older Patients
11%
Response Predictors
11%
Sham
10%
Remission
10%
Long-term Maintenance Therapy
10%
Randomized Sham-controlled Trial
10%
Multicenter Randomized Controlled Trial
10%
Multimodal Assessment
10%
Geriatric Psychiatry
10%
Buprenorphine
10%
Disease Case
10%
Threatened Preterm Birth
10%
Depressive Symptom Trajectory
10%
Takotsubo Cardiomyopathy
10%
United States
10%
Maxillofacial
10%
Hip Fracture
10%
Geriatric Depression
10%
Metallic Implants
10%
Medicine and Dentistry
Electroconvulsive Therapy
90%
Major Depressive Episode
43%
Transcranial Magnetic Stimulation
42%
Treatment Resistant Depression
34%
Third Trimester Pregnancy
23%
Executive Function
21%
Repetitive Transcranial Magnetic Stimulation
21%
Catatonia
21%
Adverse Event
18%
Late Life Depression
18%
Drug Therapy
14%
Bupropion
14%
Psychiatry
14%
Antidepressant
13%
Second Trimester Pregnancy
13%
Randomized Controlled Trial
11%
Psychological Well-Being
11%
Montgomery-Åsberg Depression Rating Scale
10%
Antidepressant
10%
Buprenorphine
10%
Low Drug Dose
10%
Psychogeriatrics
10%
Coronary Artery Disease
10%
Acute Coronary Syndrome
10%
Aortic Stenosis
10%
Implant
10%
Premature Labor
10%
Takotsubo Cardiomyopathy
10%
Adolescence
10%
Clinical Trial
8%
Aripiprazole
8%
Hamilton Rating Scale for Depression
7%
Monotherapy
7%
Nortriptyline
6%
Dorsolateral Prefrontal Cortex
6%
Randomized Clinical Trial
6%
Clinician
5%
Headache
5%
Antidepressant Medication
5%
Side Effect
5%
Maintenance Therapy
5%
Neuroscience
Transcranial Magnetic Stimulation
84%
Major Depressive Disorder
63%
Treatment-Resistant Depression
42%
Antidepressant
37%
Executive Function
23%
Electroconvulsive Therapy
17%
Late Life Depression
16%
Vagus Nerve Stimulation
14%
Venlafaxine
13%
Depression
13%
Hamilton Rating Scale for Depression
11%
Randomized Controlled Trial
11%
Executive Functions
10%
Buprenorphine
10%
Executive Dysfunction
10%
Electrical Brain Stimulation
10%
Tryptophan
10%
Psychosomatic Medicine
10%
Nitrous Oxide
10%
Placebo
9%
Bipolar Disorder
7%
Beck Depression Inventory
6%
Dorsolateral Prefrontal Cortex
6%
Mental Disorder
5%
